Collection

COVID-19 vaccination programme

Documents relating to the new coronavirus (COVID-19) vaccination programme.

From:
UK Health Security Agency
Published
27 November 2020
Last updated
2118 JulyAugust 2022 — See all updates

Blood clotting, myocarditis and pericarditis, and Guillain-Barré Syndrome (GBS)

See the COVID-19 vaccination and rare side effects for information and guidance on these very rare conditions reported after COVID-19 vaccination.

Coronaviruses are a large family of viruses that cause respiratory infections. These can range from the common cold to more serious diseases.

COVID-19 is caused by a new form of coronavirus known as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). It was first reported in December 2019.

Pregnant women who are inadvertently immunised should be notified to the Vaccine in Pregnancy surveillance programme.

Further information is available on NHS.UK and on GOV.UK

Guidance

Training resources

COVID-19 vaccination training slide set

COVID-19 vaccination e-learning programme

Consent forms and letters

Accessing COVID-19 vaccination without an NHS number

Leaflets, posters and resources

A MMR, MenACWY and COVID-19 vaccines communications toolkit for universities is available to download.

Social media resources promoting COVID-19 vaccination in migrant communities in London and nationally are available to download.

Social media resources promoting COVID-19 vaccination for pregnant women are available to download.

Surveillance

Protocols and patient group directions (PGDs)

The PGDs to support the COVID-19 vaccination programme are available to download:

PGD for Vaxzevria COVID-19 Vaccine (ChAdOx1-S [recombinant])

PGD for COVID-19 Comirnaty® 10micrograms/dose mRNA vaccine

PGD for COVID-19 Comirnaty® 30micrograms/dose mRNA vaccine

PGD for Spikevax (formerly COVID-19 Vaccine Moderna)

Programme documents

Published 27 November 2020
Last updated 2118 JulyAugust 2022 + show all updates

  1. Added 'COVID-19 vaccination: autumn booster resources'.

  2. Added 'JCVI updated statement on the COVID-19 vaccination programme for autumn 2022'.

  3. Added 'JCVI interim statement on COVID-19 autumn 2022 vaccination programme'.

  4. Added link to the Vaxzevria COVID-19 Vaccine (ChAdOx1-S [recombinant]) PGD.

  5. Added 'National protocol for Vaxzevria COVID-19 Vaccine (ChAdOx1-S [recombinant])'.

  6. Added link to updated COVID-19 vaccination training slide set.

  7. Added COVID-19 vaccination: spring booster resources and JCVI statement on COVID-19 vaccinations in 2022.

  8. Added JCVI update on advice for COVID-19 vaccination of children aged 5 to 11.

  9. Added link to updated COVID-19 vaccination training slide set.

  10. Added link to the PGD for COVID-19 Comirnaty® 10micrograms/dose mRNA vaccine.

  11. Added National protocol for Comirnaty® 10 microgram/dose COVID-19 mRNA vaccine.

  12. Added link to the updated MMR, MenACWY and COVID-19 vaccines communications toolkit for universities.

  13. Added COVID-19 vaccination: resources for children aged 5 to 11 years.

  14. Added JCVI statement on the adult COVID-19 booster vaccination programme and the Omicron variant.

  15. Added JCVI update on advice for COVID-19 vaccination of children and young people.

  16. Added 'Suspension of the 15-minute wait for vaccination with mRNA vaccine for COVID-19: UK CMOs opinion' and 'COVID-19 vaccination observation period'.

  17. Added UK vaccine response to the Omicron variant: JCVI advice and link to updated COVID-19 vaccination training slide set.

  18. Added COVID-19 vaccination in pregnancy surveillance.

  19. Updated 'Programme documents' section.

  20. Added monitoring reports of the effectiveness of COVID-19 vaccination.

  21. Added COVID-19 vaccinations received overseas.

  22. Added 'COVID-19 vaccination: checklist for parents of children aged 12 to 15 years'.

  23. Added links to social media resources aimed at pregnant women.

  24. Added COVID-19 vaccine weekly surveillance reports.

  25. Added COVID-19: provision of immunisation sessions for outbreaks in schools.

  26. Added COVID-19 vaccination: consent form for children and young people or parents.

  27. Updated COVID-19 vaccination training slide set.

  28. Added COVID-19 vaccination: booster dose resources.

  29. Added COVID-19 vaccination: resources for schools.

  30. Added COVID-19 vaccination: easy-read resources for children and young people.

  31. Added COVID-19 vaccination for people with a weakened immune system.

  32. Added Third primary COVID-19 vaccine dose for people who are immunosuppressed: JCVI advice.

  33. Added link to the MMR, MenACWY and COVID-19 vaccines communications toolkit for universities.

  34. Added link to Comirnaty® PGD.

  35. Added COVID-19 vaccination: resources for secure settings.

  36. Added link to the COVID-19 vaccination and rare side effects.

  37. Added 'National protocol for Comirnaty® COVID-19 mRNA vaccine'.

  38. Updated COVID-19 vaccination training slide set.

  39. Added COVID-19 vaccination: resources for children and young people and COVID-19 vaccination of children and young people JCVI statements.

  40. Added links to social media resources.

  41. Added link to accessing COVID-19 vaccination without an NHS number.

  42. COVID-19 vaccination training slide set updated.

  43. Added 'COVID-19 vaccination: guide for employers'.

  44. Updated COVID-19 vaccination training slide set.

  45. Added link to the COVID-19 Vaccine Moderna PGD.

  46. Added 'COVID-19 vaccine surveillance report'.

  47. Added link to updated COVID-19 vaccination training slide set.

  48. Added 'Use of the AstraZeneca COVID-19 vaccine: JCVI statement, 7 May 2021'.

  49. Updated COVID-19 vaccination training slide set.

  50. Added the national protocol for COVID-19 Vaccine Moderna.

  51. Added Use of the AstraZeneca COVID-19 vaccine: JCVI statement and link to COVID-19 vaccination and blood clotting document collection.

  52. Added 'COVID-19 vaccination: booking an appointment letter' and 'Letter from the Health and Social Care Secretary on COVID-19 vaccination phase 1 advice'.

  53. Added 'Priority groups for phase 2 of the COVID-19 vaccination programme: advice from the JCVI'.

  54. Added updated COVID-19 vaccination training slide set link, 'PHE monitoring of the effectiveness of COVID-19 vaccination' and 'Letter from the Health and Social Care Secretary on COVID-19 vaccination in people with learning disabilities'.

  55. Added easy-read consent form for adults and vaccine product information poster.

  56. COVID-19 vaccination training slide set updated.

  57. Added British Sign Language resources.

  58. Added 'Prioritising the first COVID-19 vaccine dose: JCVI statement', 'COVID-19 vaccinations and community-based social care workers', 'UK COVID-19 vaccines delivery plan' and 'Letter to the profession from the UK Chief Medical Officers on the UK COVID-19 vaccination programmes'.

  59. Added the use of human and animal products in vaccines guide.

  60. Added 'COVID-19 vaccine monitoring reports' to the surveillance section.

  61. Added 'COVID-19: enhanced surveillance of cases in vaccinated individuals'.

  62. Added COVID-19: vaccine surveillance strategy and updated COVID-19 vaccination training slide set.

  63. Added National protocol for COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant]).

  64. Added easy-read resources.

  65. Added link to the COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant]) PGD.

  66. Added: Revised COVID-19 vaccination training slide set and Priority groups for COVID-19 vaccination: advice from the JCVI, 30 December 2020.

  67. Added national protocol for COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech).

  68. Training slide set updated.

  69. Training slide set updated.

  70. Added link to COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech) PGD.

  71. Added information leaflets, consent forms and link to updated COVID-19 vaccination training slide set.

  72. Added 'COVID-19 vaccination: women of childbearing age, pregnant, planning a pregnancy or breastfeeding'.

  73. Added 'Priority groups for COVID-19 vaccination: advice from the JCVI, 2 December 2020'.

  74. First published.

Contents